Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
Sisteré-Oró M, Vergara-Alert J, Stratmann T, López-Serrano S, Pina-Pedrero S, Córdoba L, Pérez-Maillo M, Pleguezuelos P, Vidal E, Veljkovic V, Segalés J, Nielsen J, Fomsgaard A, Darji A. Sisteré-Oró M, et al. Among authors: pleguezuelos p. PLoS One. 2019 Mar 1;14(3):e0212431. doi: 10.1371/journal.pone.0212431. eCollection 2019. PLoS One. 2019. PMID: 30822308 Free PMC article.
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
Sisteré-Oró M, López-Serrano S, Veljkovic V, Pina-Pedrero S, Vergara-Alert J, Córdoba L, Pérez-Maillo M, Pleguezuelos P, Vidal E, Segalés J, Nielsen J, Fomsgaard A, Darji A. Sisteré-Oró M, et al. Among authors: pleguezuelos p. PLoS One. 2019 Sep 25;14(9):e0222201. doi: 10.1371/journal.pone.0222201. eCollection 2019. PLoS One. 2019. PMID: 31553755 Free PMC article.
Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF®01 or CDA/αGalCerMPEG.
López-Serrano S, Cordoba L, Pérez-Maillo M, Pleguezuelos P, Remarque EJ, Ebensen T, Guzmán CA, Christensen D, Segalés J, Darji A. López-Serrano S, et al. Among authors: pleguezuelos p. Vaccines (Basel). 2021 Jul 6;9(7):751. doi: 10.3390/vaccines9070751. Vaccines (Basel). 2021. PMID: 34358167 Free PMC article.
Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
Lorca-Oró C, Vila J, Pleguezuelos P, Vergara-Alert J, Rodon J, Majó N, López S, Segalés J, Saldaña-Buesa F, Visa-Boladeras M, Veà-Baró A, Campistol JM, Abad X. Lorca-Oró C, et al. Among authors: pleguezuelos p. J Infect Dis. 2022 Feb 15;225(4):587-592. doi: 10.1093/infdis/jiab551. J Infect Dis. 2022. PMID: 34904659 Free PMC article.
Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection.
Pleguezuelos P, Sibila M, Cuadrado-Matías R, López-Jiménez R, Pérez D, Huerta E, Pérez M, Correa-Fiz F, Mancera-Gracia JC, Taylor LP, Borowski S, Saunders G, Segalés J, López-Soria S, Balasch M. Pleguezuelos P, et al. Vaccines (Basel). 2022 Aug 1;10(8):1234. doi: 10.3390/vaccines10081234. Vaccines (Basel). 2022. PMID: 36016122 Free PMC article.
Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions.
Sibila M, Guevara G, Cuadrado R, Pleguezuelos P, Pérez D, Pérez de Rozas A, Huerta E, Llorens A, Valero O, Pérez M, López C, Krejci R, Segalés J. Sibila M, et al. Among authors: pleguezuelos p. Porcine Health Manag. 2020 May 4;6:11. doi: 10.1186/s40813-020-00148-0. eCollection 2020. Porcine Health Manag. 2020. PMID: 32391165 Free PMC article.
Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age.
Pleguezuelos P, Sibila M, Ramírez C, López-Jiménez R, Pérez D, Huerta E, Llorens AM, Pérez M, Correa-Fiz F, Mancera Gracia JC, Taylor LP, Smith J, Bandrick M, Borowski S, Saunders G, Segalés J, López-Soria S, Fort M, Balasch M. Pleguezuelos P, et al. Vaccines (Basel). 2022 Dec 9;10(12):2108. doi: 10.3390/vaccines10122108. Vaccines (Basel). 2022. PMID: 36560518 Free PMC article.
Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk.
Bosch-Camós L, Alonso U, Esteve-Codina A, Chang CY, Martín-Mur B, Accensi F, Muñoz M, Navas MJ, Dabad M, Vidal E, Pina-Pedrero S, Pleguezuelos P, Caratù G, Salas ML, Liu L, Bataklieva S, Gavrilov B, Rodríguez F, Argilaguet J. Bosch-Camós L, et al. Among authors: pleguezuelos p. PLoS Pathog. 2022 Nov 9;18(11):e1010931. doi: 10.1371/journal.ppat.1010931. eCollection 2022 Nov. PLoS Pathog. 2022. PMID: 36350837 Free PMC article.